跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pyresaph-250 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Pyresaph-250
Approved
STANDARD
Pyresaph-250
Enicar Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ef7c02d5cf56f703
Company
Enicar Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
ef7c02d5cf56f703
Drug Approval Philippines Name
Pyresaph-250
Product Name
Pyresaph-250
Registration Number
DRP-9569
Brand Name
Pyresaph-250
Generic Name
Paracetamol
Dosage Form
Suspension
Dosage Strength
250 mg/ 5mL
Manufacturer
Enicar Pharmaceuticals Pvt. Ltd.
Trader
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Issuance Date
26 February 2021
Expiry Date
26 February 2026
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ef7c02d5cf56f703
Type
Standard
Back to Philippines FDA Approvals